Company Filing History:
Years Active: 2006
Title: Hae-Keun Oh: Innovator in Cytoplasmic Transduction Peptides
Introduction
Hae-Keun Oh is a prominent inventor based in Daejeon Metropolitan, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of cytoplasmic transduction peptides. His innovative work has the potential to enhance drug delivery systems and immunotherapy.
Latest Patents
Hae-Keun Oh holds a patent for "Cytoplasmic transduction peptides and uses thereof." This invention relates to a cytoplasmic transduction peptide (CTP) that demonstrates transduction potential, as well as cytoplasmic remaining potential and various applications. The CTP exhibits a transduction potential that is equal to or greater than conventional protein transduction, known as PTD, and shows a strong tendency to remain in the cytoplasm. This makes it particularly useful for inducing cytotoxic T lymphocytes (CTL) and for drug delivery systems (DDS) targeting the cytoplasm.
Career Highlights
Hae-Keun Oh is associated with Creagene Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the application of scientific principles to solve real-world problems.
Collaborations
Hae-Keun Oh collaborates with notable colleagues, including Dae-You Kim and Chang-Hyun Kim. Their combined expertise contributes to the success of their projects and enhances the impact of their research.
Conclusion
Hae-Keun Oh is a distinguished inventor whose work in cytoplasmic transduction peptides holds promise for advancements in drug delivery and immunotherapy. His contributions to the field are noteworthy and continue to influence the biotechnology landscape.